27 related articles for article (PubMed ID: 38479445)
21. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.
Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W
J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445
[TBL] [Abstract][Full Text] [Related]
22. New advances into cisplatin resistance in head and neck squamous carcinoma: Mechanisms and therapeutic aspects.
Hu H; Li B; Wang J; Tan Y; Xu M; Xu W; Lu H
Biomed Pharmacother; 2023 Jul; 163():114778. PubMed ID: 37137185
[TBL] [Abstract][Full Text] [Related]
23. Nanoparticle-mediated active and passive drug targeting in oral squamous cell carcinoma: current trends and advances.
Manikkath J; Manikkath A; Lad H; Vora LK; Mudgal J; Shenoy RR; Ashili S; Radhakrishnan R
Nanomedicine (Lond); 2023 Nov; 18(27):2061-2080. PubMed ID: 38197397
[TBL] [Abstract][Full Text] [Related]
24. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma.
Chen R; Zhu S; Zhao R; Liu W; Jin L; Ren X; He H
Front Pharmacol; 2024; 15():1402514. PubMed ID: 38711989
[TBL] [Abstract][Full Text] [Related]
25.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
